Shares of Abercrombie & Fitch ( NYSE: ANF ) are flying higher on Wednesday. The company's stock had gained 15% as of 2:36 p.m. ET. The jump came as the S&P 500 and the Nasdaq Composite were mostly flat.The clothing retailer reported its first-quarter numbers before the market opened on Wednesday, ...

Analysts see Katz's return as a catalyst for revenue and margin growth. JP Morgan upgrades Vail; BofA lifts price target on leadership shift. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform-now 60% off for Memorial Day. Vail Resorts, Inc.

Ultragenyx's Q1 2025 revenue rose 28% to $139.29 million; full-year guidance was set at $640 million-$670 million. Setrusumab is projected to generate $2.4 billion in peak sales by 2037, with $1.4 billion to Ultragenyx.

Wedbush analyst Dan Ives expects Palantir and Nvidia to be the biggest beneficiaries of the AI boom. "You cannot talk AI revolution without saying Palantir," Ives says. Discover how Matt Maley trades sharp reversals-live this Wednesday, May 28 at 6 PM ET. Save your free seat now.

Shares of government technology consultancy Booz Allen Hamilton ( NYSE: BAH ) fell on Wednesday, down as much as 4.9% before recovering modestly to a 4% decline as of 1:37 p.m. ET.Booz Allen sold off by a double-digit number last Friday following its fiscal-fourth-quarter earnings release, before ...

Shares of Box ( NYSE: BOX ) surged as much as 19.7% higher on Wednesday, peaking around 1:30 p.m. ET. The cloud-based data storage and content management veteran reported robust first-quarter fiscal-year 2026 results on Tuesday evening. By 3:10 p.m.

Analyst sees Primo Brands' EBITDA rising to $1.76 billion by FY2 driven mainly by $300 million in cost synergies, not core ops improvement. Bottled water's growing U.S. market share and premium expansion support Primo's 3%-5% annual sales growth target.

Image source: The Motley Fool.Need a quote from one of our analysts? Email pr@fool.comKingsoft Cloud ( NASDAQ:KC ) management highlighted continued acceleration of AI-related business, with deployments such as the Xiaomi ( OTC:XIACY ) large language model training on Kingsoft Cloud infrastructure.

Chardan cut RP-A501 success odds from 70% to 40% due to patient death and regulatory uncertainty. Jefferies lowered Rocket's price target to $2.50 from $29, citing safety concerns. Discover how Matt Maley trades sharp reversals-live this Wednesday, May 28 at 6 PM ET. Save your free seat now.

Boston Scientific pulls ACURATE valves, citing costly regulatory demands across US and global markets. Despite the exit, the company expects to meet 2025 sales and adjusted EPS guidance set in April. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now ...